Specific genetic mutations: Detects variations in genes related to drug metabolism, such as those involved in the metabolism of lithium and valproate. Patient response to medications: Assesses whether a patient may fall into the category of “good responder,” “normal responder,” or “poor responder” to mood stabilizers. Likelihood of side effects: Provides information about the potential risk of adverse or unwanted side effects. Drug interactions: Identifies how other medications may interfere with the effectiveness of mood stabilizers.

Patients receiving mood stabilizers: To determine how their bodies respond to the medications used in treatment. Individuals experiencing side effects: To help identify if they have genetic predispositions causing adverse reactions to medications. Patients not responding to current treatment: To guide physicians toward more effective treatment options based on genetic background. Individuals with a family history of negative drug reactions: To assess risks based on family genetics. Patients taking multiple medications: To ensure no harmful interactions affect the efficacy of mood stabilizers.

Ineffective treatment response: When mood stabilizers do not achieve the desired effect in managing symptoms. Severe or unexpected side effects: Such as nausea, dizziness, or mood changes that appear after starting treatment. Family history of adverse drug reactions: If family members have experienced serious side effects with mood stabilizers. Sudden changes in mental state: Such as worsening symptoms or the appearance of new symptoms after starting treatment. Concerns about drug interactions: Especially if the patient is taking multiple medications that may affect the effectiveness of mood stabilizers.

What is pharmacogenetic testing for mood stabilizers? It is a test used to determine how genetic variations affect an individual’s response to mood stabilizers. Why is this test performed? It is conducted to improve treatment efficacy, personalize medications, and reduce side effects. How is the test performed? A blood or saliva sample is collected and analyzed in a specialized laboratory. Are there any special preparations before the test? Typically, no special preparations are needed, but it is recommended to consult a physician about any medications to avoid. What results can be expected? The results may reveal genetic mutations affecting the patient’s response to medications, helping in personalizing treatment. Can treatment be changed based on the results? Yes, the results can be used to adjust doses or select different medications. Are there any risks associated with this test? There are no major risks, though the patient may feel discomfort when the blood sample is taken. How long does it take to get the results? Results are usually available within days to weeks, depending on the laboratory.

Presence or absence of genetic mutations: Such as genes related to drug metabolism (e.g., CYP2D6 and CYP2C19). Treatment response classifications: Such as "good responder," "normal responder," or "poor responder" to mood stabilizers. Risk assessment: Identifying potential risks of side effects based on the genetic profile.

Mood Stabilizer Genetic Test | Lahalak Platform

This test provides precise insight into how your body responds to mood stabilizers, helping select the most effective treatment to enhance personalized mood balance and mental health.

Prices starts from: 1224.4 SAR

Scientific name: Pharmacogenetic Testing for Mood Stabilizers

Pharmacogenetic Testing for Mood Stabilizers is a medical test aimed at determining how genetic variations affect the body's response to mood stabilizers, such as lithium and valproate. A sample of blood or saliva is collected, and specific genes related to the metabolism of these medications are analyzed. This test helps doctors tailor treatments...

Pharmacogenetic Testing for Mood Stabilizers - Mood Medication Genetic Insight

Service type Genetic test (Blood or Saliva)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 1224.4 SAR

Included Services

Pharmacogenetic Testing for Mood Stabilizers Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Specific genetic mutations: Detects variations in genes related to drug metabolism, such as those involved in the metabolism of lithium and valproate.
Patient response to medications: Assesses whether a patient may fall into the category of “good responder,” “normal responder,” or “poor responder” to mood stabilizers.
Likelihood of side effects: Provides information about the potential risk of adverse or unwanted side effects.
Drug interactions: Identifies how other medications may interfere with the effectiveness of mood stabilizers.

Recommended groups

Patients receiving mood stabilizers: To determine how their bodies respond to the medications used in treatment.
Individuals experiencing side effects: To help identify if they have genetic predispositions causing adverse reactions to medications.
Patients not responding to current treatment: To guide physicians toward more effective treatment options based on genetic background.
Individuals with a family history of negative drug reactions: To assess risks based on family genetics.
Patients taking multiple medications: To ensure no harmful interactions affect the efficacy of mood stabilizers.

Symptoms indicative

Ineffective treatment response: When mood stabilizers do not achieve the desired effect in managing symptoms.
Severe or unexpected side effects: Such as nausea, dizziness, or mood changes that appear after starting treatment.
Family history of adverse drug reactions: If family members have experienced serious side effects with mood stabilizers.
Sudden changes in mental state: Such as worsening symptoms or the appearance of new symptoms after starting treatment.
Concerns about drug interactions: Especially if the patient is taking multiple medications that may affect the effectiveness of mood stabilizers.

FAQs

What is pharmacogenetic testing for mood stabilizers? It is a test used to determine how genetic variations affect an individual’s response to mood stabilizers.
Why is this test performed? It is conducted to improve treatment efficacy, personalize medications, and reduce side effects.
How is the test performed? A blood or saliva sample is collected and analyzed in a specialized laboratory.
Are there any special preparations before the test? Typically, no special preparations are needed, but it is recommended to consult a physician about any medications to avoid.
What results can be expected? The results may reveal genetic mutations affecting the patient’s response to medications, helping in personalizing treatment.
Can treatment be changed based on the results? Yes, the results can be used to adjust doses or select different medications.

Normal Levels

Presence or absence of genetic mutations: Such as genes related to drug metabolism (e.g., CYP2D6 and CYP2C19).
Treatment response classifications: Such as "good responder," "normal responder," or "poor responder" to mood stabilizers.
Risk assessment: Identifying potential risks of side effects based on the genetic profile.